Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis

NAEnrolling by invitationINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 2, 2022

Primary Completion Date

August 28, 2026

Study Completion Date

February 1, 2027

Conditions
Acute PancreatitisNecrosis; Pancreas, Acute (Infectious)
Interventions
DEVICE

EndoRotor® System (Interscope, Inc., Northbridge, MA USA),

The EndoRotor System is intended for use in endoscopic procedures to resect and remove necrotic debris during DEN for WON. DEN with the EndoRotor System (study device) is considered to be standard of care therapy for patients with WON and not investigational.

PROCEDURE

Conventional endoscopic devices (according to standards of care)

Endoscopic devices used to perform conventional DEN will be chosen according to standard of care and Investigator preference.

Trial Locations (12)

19107

Thomas Jefferson University Hospital, Philadelphia

35294

University of Alabama Medical Center, Birmingham

94110

California Pacific Medical Center, San Francisco

Unknown

Copenhagen University Hospital, Hvidovre

Evangelical Hospital, Düsseldorf

University of Frankfurt, Frankfurt

Humanitas Reserach Hospital & Humanitas University, Milan

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma

Amsterdam University Medical Center, Amsterdam

St. Antonius Hospital, Nieuwegein

Central Manchester University Hospital, Manchester

1076JP

Charlotte van Veldhuisen, Amsterdam

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Interscope, Inc.

INDUSTRY

lead

Erasmus Medical Center

OTHER

NCT04814693 - Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis | Biotech Hunter | Biotech Hunter